CCRM, in partnership with University Health Network, has built a Good Manufacturing Practices facility to produce cells and viral vectors for Phase 1 and 2 clinical trials. The Centre for Cell and Vector Production (CCVP) is a 20,000 sq. ft. space featuring ISO Class 7/Grade B cell and viral vector clean rooms – 10 in total. Watch our video for a view into this leading-edge facility and hear from Susan Marlin, of Clinical Trials Ontario, along with others, on why CCVP is so important for Toronto and Canada. Working with academics, cell therapy and gene therapy developers, CCRM is continuing to drive the industry closer to delivering on the promise of regenerative medicine as a possible cure for many devastating diseases and conditions.